These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6318279)

  • 21. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical efficacy of cefotaxime in two different periods.
    Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB
    J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study of a new cephalosporin: ceftriaxone (RO 13-9904) in resurgent acute and chronic bronchopneumopathies].
    Pezza A; Giacomelli P; Montella R; Casino G
    Arch Monaldi; 1983; 38(1-2):17-24. PubMed ID: 6326701
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefotaxime therapy for serious infections.
    Tanphaichitra D; Wanvarie S; Srimuang S
    J Med Assoc Thai; 1984 Feb; 67(2):108-10. PubMed ID: 6330259
    [No Abstract]   [Full Text] [Related]  

  • 26. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netilmicin alone or in combination in renal transplantation.
    Stathakis C; Kosmidis J; Boletis J; Iatrou C; Metaxatos G; Vlassis T; Chomatas J; Vosnides G
    Chemioterapia; 1987 Jun; 6(2 Suppl):497-9. PubMed ID: 3334610
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of cefotaxime in pneumology.
    Grassi C; Colombo ML; Peona V
    Acta Med Port; 1983 Feb; 4(2):87-90. PubMed ID: 6303060
    [No Abstract]   [Full Text] [Related]  

  • 29. [Basic and clinical studies on the use of cefotaxime in neonates].
    Toyonaga Y; Kurosu Y; Sugita M; Hori M
    Jpn J Antibiot; 1982 Jul; 35(7):1767-82. PubMed ID: 6294358
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of septic burns with a third-generation cephalosporin (cefatriaxon).
    Theron EJ; Nel CJ
    S Afr Med J; 1983 Nov; 64(21):816-7. PubMed ID: 6314562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of cefotaxime in infections in internal medicine].
    Kawasaki H; Suou T; Watanabe K; Yoshida K; Sasaki H; Kishimoto Y; Sugihara T; Ishitobi S; Kanno S; Tsuruhara I
    Jpn J Antibiot; 1984 Sep; 37(9):1714-28. PubMed ID: 6096586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concentration of antibiotics in various jaw tissues: concentration of ceftriaxone (Part IX)].
    Pignanelli M; Fraschini F; Santoro F; Scaglione F; Tassarotti B
    Dent Cadmos; 1984 Aug; 52(8):69-71. PubMed ID: 6098488
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of cefotaxime at Kenyatta National Hospital.
    Shah MV; Kanja C
    East Afr Med J; 1983 Mar; 60(3):196-9. PubMed ID: 6311510
    [No Abstract]   [Full Text] [Related]  

  • 36. Ceftriaxone therapy of bone and soft tissue infections in hospital and outpatient settings.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    Antimicrob Agents Chemother; 1983 May; 23(5):731-7. PubMed ID: 6307135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The activity and tolerance of ceftriaxone in the treatment of severe surgical infections].
    Erttmann M
    Wien Med Wochenschr Suppl; 1985; 87():32-5. PubMed ID: 3856975
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical efficacy of cefotaxime in the field of internal medicine].
    Saitoh H; Yamada K; Goto Y; Kobayashi M; Horigome K; Nakano N; Sakai H; Kitamura H; Satoh H; Saitoh F
    Jpn J Antibiot; 1983 Oct; 36(10):2901-12. PubMed ID: 6325749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of ceftizoxime in the treatment of paediatric infections.
    Shikuma CM; Cable DC; Edralin G; Overturf GD
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():293-5. PubMed ID: 6296023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.